Synthesis of a New Poly(ε-caprolactone)-g-Chitosan Amphiphilic Graft Copolymer with a "Reverse" Structure

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Nanotechnology

Background:

• Chitosan (CHT) and polyε-caprolactone (PCL) are biocompatible polymers with biomedical applications.
• Mixing CHT and PCL is challenging due to incompatibility, limiting their combined utility.
• Novel copolymer structures are needed to overcome limitations and enhance polymer properties.

Purpose of the Study:

• To synthesize a novel, fully biodegradable amphiphilic graft copolymer of PCL and CHT.
• To create a copolymer with an unusual "reverse" graft structure (PCL backbone with CHT grafts).
• To develop a new material for advanced drug delivery systems.

Main Methods:

• Synthesis of a "reverse" graft copolymer, poly(ε-caprolactone-g-chitosan) (PCL-g-CHT).
• Utilized copper-catalyzed 1,3-dipolar Huisgen cycloaddition reaction.
• Employed pH-independent, soluble chitosan oligomers for amphiphilicity.

Main Results:

• Successfully synthesized the amphiphilic PCL-g-CHT copolymer with a PCL backbone and CHT grafts.
• The copolymer demonstrated spontaneous self-assembly in aqueous solutions.
• Formed stable nanomicelles capable of encapsulating hydrophobic drugs.

Conclusions:

• The novel PCL-g-CHT amphiphilic copolymer overcomes CHT/PCL incompatibility issues.
• The self-assembled nanomicelles show promise as novel drug delivery systems.
• This research expands the potential applications of chitosan and PCL in biomedicine.